@article{ref1,
title="Feasibility of mobile telephonic follow-up among patients with alcohol dependence syndrome",
journal="National medical journal of India, The",
year="2019",
author="Nandyal, Munaf and Chandramouleeswaran, Susmita and Braganza, Deepa",
volume="32",
number="2",
pages="77-82",
abstract="BACKGROUND.: Losses to follow-up impact the collection of outcomes among patients with alcohol dependence syndrome (ADS). We aimed to study the feasibility and acceptability of using telephonic contact as a means of following up new patients with ADS. The outcomes assessed were complete abstinence at the end of 6 months and associated factors. <br><br>METHODS.: We followed up a cohort of 54 new patients diagnosed with ADS after 6 months, in the psychiatry department of a tertiary care hospital in India. We also assessed sociodemographic, alcohol-related, medical and treatmentrelated details of the patients; and scores on the Short Alcohol Dependence Data Questionnaire, Rotter's scale for the locus of control, and the Clinical Institute of Withdrawal Assessment of Alcohol scale-revised. The primary outcome was complete abstinence at the end of 6 months. The data at follow-up were collected through a combination of in-person and telephonic interviews with the patients and caregivers and supplemented with chart reviews. <br><br>RESULTS.: Follow-up at 6 months could be carried out for 51 of 54 patients enrolled (94.4%; 32 through direct, and 19 through telephonic interviews). The proportion of patients who achieved and maintained complete abstinence during this period was 27.5%. The factors found to be associated with abstinence were regularity of follow-up, adherence to medicines and having had the habit of drinking alcohol with friends, as opposed to solitary drinking. <br><br>CONCLUSION.: Using mobile telephonic technology, we were able to obtain an excellent follow-up and improve the collection of outcomes by 35.2% at the end of a 6-month period among new patients with ADS. This potentially effective tool is widely available and cost-effective, and could have a role in improving outcomes among patients with ADS.<p /> <p>Language: en</p>",
language="en",
issn="0970-258X",
doi="10.4103/0970-258X.275345",
url="http://dx.doi.org/10.4103/0970-258X.275345"
}